News
EVGN
1.547
-6.25%
-0.103
Evogene Sees Revenue Growth and Expands AI Collaboration
TipRanks · 12h ago
Evogene reports Q3 EPS ($1.31) vs. (81c) last year
TipRanks · 13h ago
Evogene GAAP EPS of -$1.31 misses by $0.30, revenue of $1.8M misses by $1.05M
Seeking Alpha · 13h ago
Evogene Q3 2024 GAAP EPS $(1.31) Misses $(0.63) Estimate, Sales $1.80M Miss $2.85M Estimate
Benzinga · 13h ago
Earnings Scheduled For November 21, 2024
Benzinga · 17h ago
Evogene: Q3 Earnings Snapshot
Barchart · 19h ago
Evogene Reports Third Quarter 2024 Financial Results
Barchart · 19h ago
Here's the major earnings before the open tomorrow
Seeking Alpha · 1d ago
Evogene Q3 2024 Earnings Preview
Seeking Alpha · 1d ago
A Glimpse of Evogene's Earnings Potential
Benzinga · 1d ago
Lake Street Keeps Their Buy Rating on Evogene (EVGN)
TipRanks · 2d ago
Weekly Report: what happened at EVGN last week (1111-1115)?
Weekly Report · 3d ago
Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment
TipRanks · 11/12 12:26
Weekly Report: what happened at EVGN last week (1104-1108)?
Weekly Report · 11/11 10:39
Weekly Report: what happened at EVGN last week (1028-1101)?
Weekly Report · 11/04 10:38
Lake Street Sticks to Their Buy Rating for Evogene (EVGN)
TipRanks · 10/31 12:57
Evogene announces collaboration with Google Cloud
TipRanks · 10/31 12:18
Evogene Announces Collaboration With Google Cloud To Pioneer Generative AI Foundation Model For Novel Small Molecule Design, Leveraging Evogene's Deep Expertise In Computational Predictive Biology And Google Cloud's Leadership In AI And Machine Learning
Benzinga · 10/31 12:16
Weekly Report: what happened at EVGN last week (1021-1025)?
Weekly Report · 10/28 10:32
Weekly Report: what happened at EVGN last week (1014-1018)?
Weekly Report · 10/21 10:30
More
Webull provides a variety of real-time EVGN stock news. You can receive the latest news about Evogene through multiple platforms. This information may help you make smarter investment decisions.
About EVGN
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.